Physician profile
Sheila F Friedlander
NPI 1386715043
$6,637.45
in general payments reported to CMS, 2019-2025
16 companies · $309 in 2025
The $309 reported for 2025 was more than what a typical Pediatric Dermatology provider received nationally (typical 2025 total: $302).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $4,680 · 2021: $94.79 · 2022: $149 · 2023: $531 · 2024: $529 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,101 · Education: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,100.77 |
| Education | $268.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $2,783.59 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $2,234.73 | 2019-2021 | |
| Leo Pharma INC. | $346.09 | 2024-2025 | Adbry |
| Genzyme Corporation | $340.90 | 2019-2024 | |
| Janssen Biotech, INC. | $219.85 | 2023-2024 | Tremfya |
| Arcutis Biotherapeutics, INC. | $128.79 | 2023 | |
| Ucb, INC. | $125.76 | 2023 | Cimzia |
| Incyte Corporation | $85.08 | 2022-2024 | Opzelura |
| Sanofi-Aventis U.S. LLC | $70.51 | 2021 | |
| Sun Pharmaceutical Industries INC. | $68.99 | 2024 | |
| Celgene Corporation | $64.58 | 2019 | |
| Abbvie INC. | $52.00 | 2023 | |
| Verrica Pharmaceuticals INC. | $47.17 | 2025 | Ycanth |
| E.R. Squibb & Sons, L.L.C. | $31.56 | 2024 | Sotyktu |
| Greenwich Biosciences, INC. | $20.03 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.82 | 2023 | Jublia, Arazlo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheila Friedlander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.